Belrise Industries IPO received 2.88 times subscription on Day 2, with strong demand from non-institutional investors. The issue will conclude on May 23. Read more.

Belrise Industries' IPO was subscribed 2.88 times on its second day, with non-institutional investors showing significant ...

The current grey market premium of Belrise Industries is now 15.56 per cent based on the upper IPO price of 90, indicating ...

Alivus Life Sciences Ltd (Alivus), previously Glenmark Life Sciences, operates as a developer and manufacturer of active ...